Navigation Links
CV risk management should be mandatory in RA and other types of inflammatory rheumatic disease
Date:6/13/2008

the CV management targets should be set according to local guidelines. If there are no local guidelines, treatment should be considered when the 10 year CV mortality risk with the (newly adapted) Framingham/SCORE function is above a certain value.

  • Aggressive inflammation suppression is recommended to further lower the CV risk in patients with inflammatory rheumatic disease.

    Dr Michael Nurmohamed, lead investigator and convenor of this EULAR Task Force said, "Although traditional cardiovascular risk factors occur more frequently in patients with inflammatory rheumatic disease than in the general population, they only partially explain these patients' increased cardiovascular risk. There is mounting evidence that inflammation may be the missing link. Therefore, disease modifying antirheumatic drugs (DMARD) and biologics may lower the cardiovascular risk in inflammatory rheumatic disease patients, whilst statins and hypertensives, such as ACE inhibitors and angiotensin blockers, may even yield greater benefits than in the general population due to their anti-inflammatory properties."

    Professor Ferdinand Breedveld, President of EULAR said, "These recommendations have been developed in accordance with the EULAR Standardised Operating Procedures and in line with the EULAR objectives to improve the understanding of musculoskeletal disorders and contribute to the improvement of outcome of patients with rheumatic disorders. The Task Force is to be commended on its excellent recommendations which will directly contribute to improved clinical practice and better understanding of the management of CV factors in rheumatology."

    CV risk factor stratification and management is currently conducted on the basis of 10 years absolute risk for a (fatal) CV-event, as derived from a risk formula based on a number of CV-risk factors. The two major standard CV risk calculators are Framingham, a tool based on US population statistics and SCORE,
    '/>"/>


  • Contact: Rory Berrie / Camilla Dormer
    eularpressoffice@uk.cohnwolfe.com
    44-077-892-70392
    European League Against Rheumatism
    Source:Eurekalert

    Page: 1 2 3

    Related medicine news :

    1. Birner Dental Management Services, Inc. Declares $.17 Quarterly Dividend
    2. Rising Medical Solutions Chooses Bank of America to Bring Enhanced Cash Management and Provider Payment Solutions to the Marketplace
    3. Cancer Clinics of Excellence (CCE) Announces Management and Board of Directors Slate at 1st Annual General Membership Meeting
    4. Benchmarking Study Report on Sales Performance Management
    5. New self-management program offers significant benefits for arthritis patients with chronic pain
    6. Edge Health Solutions Releases edgeDMS(TM) 2.0 and edgeMD 2.0(TM), Revolutionary All-in-One Practice Management Software with FDA-Approved Advanced Visualization
    7. Medical Mutual of Ohio Receives URAC Utilization Management Accreditation
    8. Rush-Copley Medical Center Selects Allscripts Electronic Health Record and Practice Management Solution
    9. Weight Management Solution Helps You Lose or Gain as Much Weight as You Choose
    10. Aribex(R) Continues Growth With New Management, Organization
    11. ECRI Institutes Alert and Recall Management System Expands Effectiveness with New Content and Filters
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/23/2014)... Village, CA (PRWEB) September 23, 2014 ... Dental Office is now offering complimentary oral sedation with ... 15 percent of Americans suffer from dental anxiety or ... uncomfortable for patients; they can also keep patients from ... anxiety or phobia in Westlake Village and surrounding areas ...
    (Date:9/23/2014)... YORK, NY (PRWEB) September 23, 2014 ... best innovators in the pharmaceutical industry with their annual ... bestowed at a gala banquet at Gotham Hall in ... and brand managers representing top talent and brands. ... celebrate its accomplishments,” says Anna Stashower, CEO and Publisher ...
    (Date:9/23/2014)... Gurnee, IL (PRWEB) September 23, 2014 ... lighting solutions, has expanded its MedMaster™ M4 product ... The luminaire extends the M4 product line – ... green LED options – providing more flexibility when ... of the MedMaster M4 Series include:, ...
    (Date:9/23/2014)... 2014 The U.S. Pharmacopeial Convention (USP) ... Health Organization (WHO) regarding the assignment of Biological Qualifiers ... by the Expert Group of the Programme of International ... to the naming of all biologicals that is consistent ... assessment of these drugs. , Hence, USP supports ...
    (Date:9/23/2014)... N.J. (PRWEB) September 23, 2014 ... provider of advanced delivery technologies and development ... products, today announced that it had reached ... privately held biopharmaceutical company, Cingulate Therapeutics (CTx), ... of new prescription pharmaceutical products for the ...
    Breaking Medicine News(10 mins):Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 2Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 3Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 2Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 3Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 4Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 5Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 6Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 2Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 3Health News:USP Comments to WHO Regarding Biologics Qualifier Proposal 2Health News:Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments 2Health News:Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments 3
    ... military recreation managers to assist service ... members returning to active duty, ... military,personnel have been wounded by hostile and nonhostile acts in ... care, recreation,programming is playing an important role in reintegrating these ...
    ... history, study finds , , WEDNESDAY, Nov. 5 (HealthDay News) -- ... concern among parents when it comes to assessing their children,s ... by researchers at the University of Michigan C.S. Mott Children,s ... too much clout to a genetic test result. , "We ...
    ... team up to talk sex secrets, one night stands and ... Staying Alive,Foundation and SpinVox have teamed up with Lapeno, Mervin ... promote sexual health amongst,young people., The Telling It Like ... to speak openly about sex, sexual health and,HIV/AIDS. Young people ...
    ... Institute touts Grekos, breakthrough in Biomedical,Technology, WASHINGTON, ... http://www.RepairStemCells.org ) today announced that its Science ... present Emerging Frontiers in,Regenerative Stem Cell Therapy: Current ... Treatment of Various End Stage Diseases, at the,2008 ...
    ... Dynamics Research,Corporation (Nasdaq: DRCO ), ... technology and information technology services and,solutions to ... it,received an $11.4 million task order under ... indefinite delivery and indefinite,quantity (ID/IQ) contract, to ...
    ... Ingenious Med (IM), the leader in,inpatient practice ... groups and meet the increasing demand for a ... wide. Specialists are,quickly becoming an ever-growing segment of ... that Arizona based Cardiovascular Associates of Mesa,(CAM) joins ...
    Cached Medicine News:Health News:Penn State Program To Help Wounded Warriors 2Health News:Most Parents Don't Overreact to Child Gene Tests 2Health News:Stars to 'Tell It Like It Is' at MTV's European Music Awards 2Health News:Stars to 'Tell It Like It Is' at MTV's European Music Awards 3Health News:Zannos Grekos, MD to Present Clinical Results of Regenerative Stem Cell Treatments to the Dubai Congress on Anti-Aging and Aesthetic Medicine 2Health News:Zannos Grekos, MD to Present Clinical Results of Regenerative Stem Cell Treatments to the Dubai Congress on Anti-Aging and Aesthetic Medicine 3Health News:Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract 2Health News:Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract 3Health News:Ingenious Med Adds Specialists to Clientele, Cardiovascular Group 2
    (Date:9/22/2014)... Sept. 22, 2014 Paragon 28, ... commercial launch of its foot plating system that supplants ... The GORILLA TM R3CON PLATING SYSTEM greatly enhances ... TM & Mini-Monster TM Screw Systems and ... of 10 interchangeable subsystems, the GORILLA TM R3CON ...
    (Date:9/22/2014)... 2014 Research and Markets  has announced ... 2014-2018" report to their offering. ... comprehensive and up-to-date publication available covering the neurotechnology industry. ... markets, competitors, and growth rates in four key segments ... 2018. It forecasts the number of systems to be ...
    (Date:9/22/2014)... , Sept. 22, 2014  Elusys Therapeutics, Inc. ... treat infectious disease, today announced it has completed ... of obiltoxaximab (ETI-204). Obiltoxaximab is an anti-toxin in ... data from these studies support the safety and ... at the intended therapeutic dose. The conclusion of ...
    Breaking Medicine Technology:Paragon 28, Inc. Launches the GORILLA(TM) R3CON PLATING SYSTEM 2The Market for Neurotechnology: 2014-2018 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6
    ... 20 Muscadine grape skin powder, from ... /), provided significant protection against radiation damage in an ... reported in April of 2009 at the 100th Annual ... Denver, Colorado.(Logo: http://www.newscom.com/cgi-bin/prnh/20090420/CL01715 )The ...
    ... prototype 3D display exceeds performance expectations.LIVONIA, Mich., April 20 ... Heritage Hospital surgeons and their medical support team assembled to ... test the new LifeVision(TM) family of 3D technologies developed by ... event marks the first time in history that ...
    Cached Medicine Technology:Muscadine Grape Skin Dietary Supplement Protects against Cancer Therapy Radiation Side Effects 2Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 2Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 3Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 4
    Ribbon malleable, general purpose retractor....
    The Wire Cutters are designed to cut Kirschner wires up to 2.5 mm diameter easily and smoothly. They are particularly useful for external fixation applications. The Wire Cutters shear fixation wires ...
    The osteotome shafts are manufactured with stainless steel and are available both straight and curved in 1/4" and 1/2" sizes....
    ... Pulse CDC Compact Cardiac Digital Camera is a ... open, patient-friendly gantry, and provides full sized fields ... into your clinic you need a flexible system ... Find out how the Pulse reduces the ...
    Medicine Products: